Identifying signals of disproportionate reporting for calcitonin gene-related peptide inhibitors: real-world evidence from the FDA adverse event reporting system
This study highlights CGRP inhibitor-associated AEs, underscoring the need for clinical monitoring and risk identification. Early detection of AEs and SDRs can inform protective measures to enhance patient safety.
Authors
- Nai Lee
- Su‐jin Rhee (ORCID: https://orcid.org/0000-0002-4010-0837)
- Yun Kim (ORCID: https://orcid.org/0000-0002-9809-7351)
- Yonghoon Kwon (ORCID: https://orcid.org/0000-0002-6232-4305)
- Jihoon Ok
Institutions
- Daegu Catholic University (KR)
- Wonkwang University (KR)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1080/14740338.2025.2497394
- Citations
- 2
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 2.61
Funders
- National Research Foundation of Korea